Brevan Howard Capital Management LP
Institutional investor · Portfolio as of Q2 2022
Top Holdings48 positions
SPDR GOLD TR | 3.6M | $604.5M | 24.9% | — | — | — | Increased — |
ISHARES TR | 6.4M | $469.5M | 19.3% | — | — | — | New — |
ISHARES TR | 3.4M | $252.3M | 10.4% | — | — | — | Decreased — |
ISHARES TR | 2.3M | $248.1M | 10.2% | — | — | — | Increased — |
ISHARES TR | 2.1M | $179.2M | 7.4% | — | — | — | New — |
ISHARES SILVER TR | 6.9M | $129.2M | 5.3% | — | — | — | Increased — |
SELECT SECTOR SPDR TR | 1.6M | $116.1M | 4.8% | — | — | — | New — |
SELECT SECTOR SPDR TR | 1.2M | $89.1M | 3.7% | — | — | — | New — |
ISHARES TR | 565,200 | $62.2M | 2.6% | — | — | — | New — |
VANECK ETF TRUST | 1.9M | $53.3M | 2.2% | — | — | — | Unchanged — |
ISHARES TR | 1.5M | $50.9M | 2.1% | — | — | — | New — |
MODERNA INC | 280,000 | $40M | 1.6% | $149.12 | -4.23% | 2 qtrssince 2022-Q1 | Increased 75 |
ISHARES TR | 450,000 | $38.4M | 1.6% | — | — | — | Decreased — |
GLOBAL X FDS | 1.7M | $31.8M | 1.3% | $19.16 | -15.41% | 4 qtrssince 2021-Q3 | Increased 70 |
CME GROUP INC | 102,553 | $21M | 0.9% | $64.90 | +164.06% | 14 qtrssince 2016-Q1 | Unchanged 0 |
TPG RE FINANCE TRUST INC | 707,942 | $6.4M | 0.3% | $6.37 | -16.64% | 2 qtrssince 2022-Q1 | Increased 44 |
| 3.6M | $3.8M | 0.2% | — | — | — | New 45 | |
ISHARES INC | 157,000 | $3.5M | 0.1% | $18.85 | -17.97% | 2 qtrssince 2022-Q1 | Unchanged 0 |
EXPAND ENERGY CORPORATION | 41,800 | $3.4M | 0.1% | $67.91 | 0.00% | 1 qtr | New 45 |
VALE S A | 195,396 | $2.9M | 0.1% | $9.90 | +1.30% | 3 qtrssince 2021-Q4 | Increased 52 |
Brevan Howard Capital Management LP manages $2.4B across 48 positions as of Q2 2022. Top holdings: GLD calls (24.9%), HYG calls (19.3%), HYG puts (10.4%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
Active quarter - 23 new positions, 12 exits, 7 increased. Top move: MRNA (INCREASED, conviction 75). Portfolio: $2.4B across 48 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR